reMYND
Pre-clinicalby pioneering innovative and effective treatments for neurodegenerative diseases, shaping a healthier future
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $60M
About
by pioneering innovative and effective treatments for neurodegenerative diseases, shaping a healthier future
NeuroscienceAlzheimer's Disease
Funding History
3Total raised:$60M
Series C$30MNov 15, 2015
Series B$20MSep 15, 2013
Series A$10MJun 15, 2011